ARS Pharmaceuticals Inc Stock, NASDAQ:SPRY
11682 El Camino Real, Suite 120, San Diego, California 92130
United States of America
Number of Employees: 90
ARS Pharmaceuticals, Inc. engages in developing neffyâ„¢, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. The company is headquartered in San Diego, CA.